Logo

Biognosys: Beat Lüthi

May 20, 2022

Swiss proteomics firm Biognosys has appointed Beat Lüthi as board director. Lüthi is CEO of CTC Analytics, a privately held Swiss laboratory automation and sample handling technology company. He is also chairman of the board of Inficon Group; vice chairman of Straumann Group; and a board member at Skan AG. He holds an MSc in electrical engineering and a PhD in business administration from ETH Zurich.

Breaking News
The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.